Milligan, G. and Inoue, A. (2018) Genome editing provides new insights into receptor-controlled signalling pathways. Trends in Pharmacological Sciences, 39(5), pp. 481-493. (doi: 10.1016/j.tips.2018.02.005) (PMID:29548548)
|
Text
157021.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 2MB |
Abstract
Rapid developments in genome editing, based largely on CRISPR/Cas9 technologies, are offering unprecedented opportunities to eliminate the expression of single or multiple gene products in intact organisms and in model cell systems. Elimination of individual G protein-coupled receptors (GPCRs), both single and multiple G protein subunits, and arrestin adaptor proteins is providing new and sometimes unanticipated insights into molecular details of the regulation of cell signalling pathways and the behaviour of receptor ligands. Genome editing is certain to become a central component of therapeutic target validation, and will provide pharmacologists with new understanding of the complexities of action of novel and previously studied ligands, as well as of the transmission of signals from individual cell-surface receptors to intracellular signalling cascades.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Milligan, Professor Graeme |
Authors: | Milligan, G., and Inoue, A. |
College/School: | College of Medical Veterinary and Life Sciences > School of Molecular Biosciences |
Journal Name: | Trends in Pharmacological Sciences |
Publisher: | Elsevier |
ISSN: | 0165-6147 |
ISSN (Online): | 1873-3735 |
Published Online: | 13 March 2018 |
Copyright Holders: | Copyright © 2018 Elsevier Ltd. |
First Published: | First published in Trends in Pharmacological Sciences 39(5): 481-493 |
Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record